K
Kazuya Terabe
Researcher at National Institute for Materials Science
Publications - 191
Citations - 8980
Kazuya Terabe is an academic researcher from National Institute for Materials Science. The author has contributed to research in topics: Thin film & Neuromorphic engineering. The author has an hindex of 41, co-authored 175 publications receiving 7924 citations.
Papers
More filters
Journal ArticleDOI
Tbit/Inch 2 Data Storage Using Scanning Nonlinear Dielectric Microscopy
Yasuo Cho,Kenjiro Fujimoto,Yoshiomi Hiranaga,Yasuo Wagatsuma,Atsushi Onoe,Kazuya Terabe,Kenji Kitamura +6 more
TL;DR: In this article, a nano-sized inverted domain remained stably for a long time and successfully formed inverted domain dots at a data density of 1.50 Tbit/inch 2, representing the highest memory density for rewritable electric data storage reported to date.
Journal ArticleDOI
Solid state ionics for the development of artificial intelligence components
TL;DR: In this article , the authors provide an overview of solid state ionics and various solid-state ionics devices that have been developed to date, with emphasis on recently introduced solid-State Ionics devices made of solid electrolytes and mixed conductors, which are expected to be indispensable for the future development of information and communication equipment.
Journal ArticleDOI
Oxide ion and proton conduction controlled in nano-grained yttria stabilized ZrO2 thin films prepared by pulse laser deposition
Daiki Etoh,Daiki Etoh,Takashi Tsuchiya,Takashi Tsuchiya,Makoto Takayanagi,Makoto Takayanagi,Tohru Higuchi,Kazuya Terabe +7 more
Early aggressive intervention with tocilizumab for rheumatoid arthritis increases remission rate defined using a Boolean approach in clinical practice Toshihisa KojimaAtsushi KanekoYuji HiranoHisato IshikawaHiroyuki MiyakeHideki Takagi • Yuichiro YabeTakefumi KatoKenya TerabeNaoki FukayaHiroki TsuchiyaTomone Shioura • Koji FunahashiMasatoshi HayashiDaizo KatoHiroyuki MatsubaraNaoki Ishiguro
Takayuki Kojima,K. Funahashi,M. Hayashi,Daiki Kato,H. Matsubara,Naotaka Ishiguro,A. Kaneko,Y. Hirano,H. Ishikawa,H. Miyake,Takagi H. Tsuchiya,Yuichiro Yabe,Tatsuhisa Kato,Kazuya Terabe,N. Fukaya,T. Shioura +15 more
TL;DR: It is shown that remission, as newly defined using a Boolean approach, is a realistic goal for patients treated with tocilizumab with short disease duration in real-world clinical practice.